Search

everythinglearnresearchcommunity

for

Search:↓

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Etanercept may not prevent alopecia areata from coming back.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

People with alopecia areata may have a higher risk of blood clots.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

RE-ORGA, a Korean herb extract, may help prevent hair loss.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Male hormones worsen kidney transplant damage, but blocking them helps.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Astragaloside IV may help prevent hair loss by blocking a specific pathway that leads to cell death.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Epithelial-mesenchymal interactions control hair growth cycles through specific molecular signals.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

STAT5 activation is crucial for starting the hair growth phase.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.